Patents by Inventor Andre Robert
Andre Robert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20060147584Abstract: A confectionery product comprising low density chocolate surrounded by a sugar-based coating, and a process for producing the confectionery product. The confectionery product is shelf stable, even at elevated ambient temperatures.Type: ApplicationFiled: December 23, 2003Publication date: July 6, 2006Applicant: Mars IncorporatedInventor: Andre Robert
-
Patent number: 4891382Abstract: A method for the prevention of pancreatitis utilizing cis- and trans-N-(3-aminocycloaliphatic)-2-arylacetamide derivative compounds of the formula ##STR1## e.g., N-[2-(n',N'-dimethylamino)cyclohexyl]-N-methyl-2-(4-bromophenyl)acetamide and trans-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]acetamide, 2-(3,4-dichlorophenyl) and their pharmaceutically acceptable salts.Type: GrantFiled: April 22, 1988Date of Patent: January 2, 1990Assignee: The Upjohn CompanyInventors: Cleo Lancaster, Andre Robert
-
Patent number: 4847860Abstract: In a receiving station having an adaptive receiving antenna, a phasing system comprises a plurality of reception paths receiving telecommunications signals derived from the same useful signal combined in transmission with a disturbing signal having a frequency band outside the frequency band of the useful signal, via a plurality of primary sources of the receiving antenna. The phasing system includes a narrowband filtering circuit for filtering the overall telecommunications signal in one of the reception paths to derive a reference signal undisturbed by the disturbing signal and solely dependent on the useful signal. In phasing circuits respectively assigned to the reception paths, the useful signal alone is set to a phase as close as possible to the phase of the reference signal in order to obtain, after signal summing at outputs of the phasing circuits, a maximum power using signal mixed with an attenuated scrambling signal.Type: GrantFiled: April 1, 1986Date of Patent: July 11, 1989Assignee: Societe Anonyme de TelecommunicationsInventor: Andre Robert
-
Patent number: 4728748Abstract: Lightning conductor with a piezoelectric device for starting the corona effect. A lightning conductor pole rests on a support fixed by means of a ball. Under the action of the wind, the pole moves out of the vertical position until a shoulder abuts against a flange of the support. With the wind continuing to act on the pole, the latter exerts a considerable force on the support and the reaction force or torque is transmitted to the piezoelectric device by means of the ball.Type: GrantFiled: April 13, 1987Date of Patent: March 1, 1988Assignee: Commissariat a l'Energie AtomiqueInventors: Andre Robert, Michel Roubinet, Jacques Baumann
-
Patent number: 4540139Abstract: A passive homing system for missiles is provided having at least three interferometric bases each comprising two electromagnetic antennae disposed on the missile. Said three interferometric bases have respective mid-perpendicular planes which are inclined two by two at 120.degree. with respect to each other.Type: GrantFiled: July 20, 1983Date of Patent: September 10, 1985Assignee: Societe Anonyme de TelecommunicationsInventors: Pierre Levy, Andre Robert
-
Patent number: 4540140Abstract: The process consists in guiding the missile firstly by an electromagnetic guidance by interferometric bases up to the proximity of the target, then by infrared guidance up to the target. Electromagnetic guidance is effected by maintaining constant the angle (.alpha.) between the velocity vector (V) of the missle (E) and the straight line (R") passing through the missile (E) and the projection (C") of the target (C) on the earth (S). The process is particularly applicable to the interception of targets travelling at low altitude above the sea.Type: GrantFiled: July 20, 1983Date of Patent: September 10, 1985Assignee: Societe Anonyme de TelecommunicationsInventors: Pierre Levy, Andre Robert
-
Patent number: 4518816Abstract: The present invention relates to a lightning conductor with a piezoelectric device for initiating the corona effect.It comprises a metal rod terminated by a tip and connected to the ground by an electric conductor. In the vicinity of the tip are provided one or more electrodes, which are electrically connected to one or more piezoelectric crystals, on which a means exerts a mechanical pressure. This makes it possible to raise the electrodes to an adequate potential for producing charged particles in the vicinity of the tip.Type: GrantFiled: March 23, 1984Date of Patent: May 21, 1985Assignee: Commissariat a l'Energie AtomiqueInventor: Andre Robert
-
Patent number: 4447305Abstract: Process for obtaining luminescent glass layers, application to the production of devices provided with said layers and to the construction of photoscintillators.The process comprises projecting onto a support, by cathodic sputtering, the material of at least one target, each target including silica and at least one chemical compound able to give luminescent centers, such as a cerium oxide, so as to form at least one luminescent glass layer of the said support. The layer or layers formed preferably undergo a heat treatment such as annealing in order to increase the luminous efficiency thereof. It is in this way possible to form a scintillating glass layer on the previously frosted entrance window of a photomultiplier in order to obtain an integrated photoscintillator.Type: GrantFiled: April 12, 1982Date of Patent: May 8, 1984Assignees: Commissariat a l'Energie Atomique, Centre National de la Recherche ScientifiqueInventors: Rudolf Heindl, Andre Robert
-
Patent number: 4439445Abstract: The present invention provides a method for gastrointestinal cytoprotection using a class of oxamic acids and derivatives thereof.Type: GrantFiled: April 8, 1982Date of Patent: March 27, 1984Assignee: The Upjohn CompanyInventors: Andre Robert, Cleo Lancaster
-
Patent number: 4424227Abstract: The present invention provides a method for gastrointestinal cytoprotection using a class of heterocyclic sulfonamides.Type: GrantFiled: May 5, 1982Date of Patent: January 3, 1984Assignee: The Upjohn CompanyInventor: Andre Robert
-
Patent number: 4397865Abstract: The present invention provides a method for the prevention of renal papillary necrosis induced by non-steroidal anti-inflammatory compounds (NOSAC) comprising the administration of certain prostaglandins.Type: GrantFiled: October 12, 1982Date of Patent: August 9, 1983Assignee: The Upjohn CompanyInventors: Andre Robert, George A. Elliott
-
Patent number: 4367649Abstract: An acoustic polarimeter for measuring the anisotropy of a sample comprises an electroacoustic transducer which transmits a high-frequency transverse acoustic wave and is fixed on a birefringent measuring plate. The acoustic wave is received by a second transducer and this latter is sensitive to the component of the wave which is parallel to the transmitted wave. Transmission devices are provided for delivering electrical signals which are frequency-modulated about a tunable mean frequency. The electrical signals applied to the second transducer are received on a zero indicator, thus permitting determination of the directions of the slow axis and fast axis of the sample as well as the angle of phase shift introduced by the sample.Type: GrantFiled: January 26, 1981Date of Patent: January 11, 1983Assignee: Thomson-CSFInventors: Jean Rouge, Andre Robert
-
Patent number: 4208427Abstract: The present invention relates to a method for the prophylaxis and treatment of the diarrheogenic effects of enteropooling inducers by administration of an anti-enteropooling dose of an 11-oxo-prostaglandin or a prostacyclin.Type: GrantFiled: January 2, 1979Date of Patent: June 17, 1980Assignee: The Upjohn CompanyInventor: Andre Robert
-
Patent number: 4197499Abstract: A telecontrol order transmission system having at the transmitting end a source, for generating ergodic random signals x(t), a circuit for alternately delivering the sum and the difference of signals x(t) and x(t-T.sub.1), which circuit is switched at the rate of a frequency f.sub.c and, at the receiving end, a multiplier multiplies a received signal by said received signal delayed by time lapse T.sub.i, an integrator for time averaging the output of said multiplier, a band-pass filter with a narrow bandwidth centered about frequency f.sub.c, connected to the output of said integrator, and a circuit for deriving a telecontrol order from the output of said filter.Type: GrantFiled: December 4, 1978Date of Patent: April 8, 1980Assignee: Societe Anonyme de TelecommunicationsInventors: Michel B. F. Henry, Louis M. P. d'Izarny-Gargas, Andre Robert
-
Patent number: 4138894Abstract: The device comprises an elongated acoustic wave translating isotropic body and a pair of transducers applied over one of the two parallel end faces thereof. Said transducers are arranged with relatively crossed axes of linear transversal polarization. The other end face of the isotrope body is intended to be applied to a sample or a structure made of an acoustically active substance presenting anisotropy, either intrinsic or induced, with respect to acoustical polarization. The length of the isotropic body is such that when the transducers are both simultaneously driven by pulsed high frequency voltages which are modulated in respective phase quadrature by a low frequency oscillation, the two transversal acoustic waves propagated through the body vectorially combine so that the opposite end face of the body is the subject of a constant amplitude acoustic wave which rotates at the speed of the pulsation of the low frequency.Type: GrantFiled: December 12, 1975Date of Patent: February 13, 1979Assignee: L'Electronique AppliqueeInventors: Andre Robert, Jean Rouge
-
Patent number: 4097603Abstract: The present invention provides a method for prophylaxis of certain gastric inflammatory diseases by administration of gastric cytoprotective prostaglandins. Gastric cytoprotective prostaglandins refer to those prostaglandin-type compounds which are useful in reducing or preventing development of ulcers and other gastric lesions in the rat challenged by ingestion of ethanol, but which exhibit substantially no gastric antisecretory effects at the effective dosage for the present method.Type: GrantFiled: September 6, 1977Date of Patent: June 27, 1978Assignee: The Upjohn CompanyInventor: Andre Robert
-
Patent number: 4088784Abstract: The present invention provides a method for treatment of Crohn's disease, inflammatory bowel disease, infectious enteritis, sprue, and intestinal inflammatory disease secondary to radiation exposure or an intestinally-manifested allergic response to foodstuffs which comprises administrating a cytoprotective prostaglandin to a human who suffers from one of said diseases. Cytoprotective prostaglandins refer to those prostaglandin-type compounds which are useful in reducing the incidence of NOSAC-induced lesions in the intestinal wall of the rat. "NOSAC" is an abbreviation for "non-steroidal antiinflammatory compound".Type: GrantFiled: June 13, 1977Date of Patent: May 9, 1978Assignee: The Upjohn CompanyInventor: Andre Robert
-
Patent number: 4083998Abstract: The present invention provides a method for treatment or prophylaxis of certain inflammatory diseases of the mammalian large intestine which comprises administrating a cytoprotective prostaglandin to a mammal who suffers from or is particularly susceptible to said inflammatory diseases of the large intestine. Cytoprotective prostaglandins refer to those prostaglandin-type compounds which are useful in reducing the incidence of NOSAC-induced lesions in the intestinal wall of the rat. "NOSAC" is an abbreviation for "nonsteroidal antiinflammatory compound.Type: GrantFiled: February 17, 1976Date of Patent: April 11, 1978Assignee: The Upjohn CompanyInventor: Andre Robert
-
Patent number: 4081553Abstract: The present invention provides a method for treatment of Crohn's disease, inflammatory bowel disease, infectious enteritis, sprue, and intestinal inflammatory disease secondary to radiation exposure or an intestinally-manifested allergic response to foodstuffs which comprises administrating a cytoprotective prostaglandin to a human who suffers from one of said diseases. Cytoprotective prostaglandins refer to those prostaglandin-type compounds which are useful in reducing the incidence of NOSAC-induced lesions in the intestinal wall of the rat. "NOSAC" is an abbreviation for "non-steroidal antiinflammatory compound.Type: GrantFiled: February 17, 1976Date of Patent: March 28, 1978Assignee: The Upjohn CompanyInventor: Andre Robert
-
Patent number: 4061742Abstract: There is disclosed concomitant systemic administration of certain prostaglandins of the PGE-type and PGA-type, for example, 16,16-dimethyl-PGE.sub.2 of 16,16-dimethyl-PGA.sub.2, and a prostaglandin synthetase inhibitor, for example, indomethacin, aspirin, or phenylbutazone, to mammals, including humans. Thereby the undesirable gastrointestinal effects of the synthetase inhibitor are reduced.Type: GrantFiled: August 9, 1976Date of Patent: December 6, 1977Assignee: The Upjohn CompanyInventor: Andre Robert